Guggenheim Downgrades Incyte to Neutral, Maintains Price Target to $92

Benzinga · 03/18 14:04
Guggenheim analyst Michael Schmidt downgrades Incyte (NASDAQ:INCY) from Buy to Neutral and maintains the price target from $92 to $92.